Sign in
4

Changes in Ownership

ENANTA PHARMACEUTICALS INC Filed Acc 0001177648-18-000048

Options or other derivatives

  • Senior Vice President acquired 18,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Ocain Tim · Senior Vice President

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2018-11-16 Grant or award : show line 1 in the form Stock Option (right to buy) +18,000 $81.20 2028-11-16 18,000 18,000 D
Loading xslF345X03/edgar.xml…